$584 Million is the total value of M.D. Sass, Inc.'s 50 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 45.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APG | Buy | API GROUP CORP | $39,723,000 | +0.8% | 1,888,855 | +23.6% | 6.80% | +11.1% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $38,144,000 | +89.0% | 146,160 | +59.1% | 6.53% | +108.2% |
| GOOGL | Buy | ALPHABET INCcap stk cl a | $36,297,000 | +164.5% | 13,050 | +175.5% | 6.21% | +191.4% |
| ON | Buy | ON SEMICONDUCTOR CORP | $34,820,000 | +26.4% | 556,142 | +37.1% | 5.96% | +39.3% |
| WD | Buy | WALKER & DUNLOP INC | $31,902,000 | -6.4% | 246,500 | +9.2% | 5.46% | +3.2% |
| QRVO | Buy | QORVO INC | $31,509,000 | -14.0% | 253,904 | +8.3% | 5.39% | -5.3% |
| CTVA | New | CORTEVA INC | $30,359,000 | – | 528,165 | +100.0% | 5.20% | – |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $25,322,000 | +50.6% | 162,666 | +23.2% | 4.33% | +65.8% |
| BC | Buy | BRUNSWICK CORP | $21,655,000 | +2.0% | 267,716 | +27.0% | 3.71% | +12.3% |
| CHE | Buy | CHEMED CORP NEW | $20,788,000 | +33.6% | 41,037 | +39.5% | 3.56% | +47.2% |
| IBKR | New | INTERACTIVE BROKERS GROUP IN | $20,130,000 | – | 305,423 | +100.0% | 3.44% | – |
| Buy | COLLABORATIVE INVESTMNT SERtuttle cap short | $3,927,000 | +1661.0% | 84,900 | +1315.0% | 0.67% | +1820.0% | |
| FB | Buy | META PLATFORMS INCcl a | $2,305,000 | -27.7% | 10,365 | +9.4% | 0.39% | -20.4% |
| SJB | New | PROSHARES TRshrt hgh yield | $1,218,000 | – | 67,315 | +100.0% | 0.21% | – |
| TTT | New | PROSHARES TRulsh 20yrtre new | $940,000 | – | 23,120 | +100.0% | 0.16% | – |
| TMV | New | DIREXION SHS ETF TR20yr tres bear | $600,000 | – | 8,355 | +100.0% | 0.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 40 | Q3 2023 | 20.1% |
| METLIFE INC | 27 | Q4 2019 | 3.7% |
| PFIZER INC | 26 | Q4 2019 | 0.4% |
| SPDR S&P 500 ETF TR | 25 | Q3 2023 | 18.0% |
| LIBERTY MEDIA CORP DELAWARE | 23 | Q2 2023 | 5.4% |
| NRG ENERGY INC | 23 | Q3 2021 | 5.6% |
| APOLLO GLOBAL MGMT LLC | 23 | Q2 2019 | 0.9% |
| ISHARES TR | 22 | Q3 2023 | 0.6% |
| DELTA AIR LINES INC DEL | 21 | Q2 2020 | 4.6% |
| ALPHABET INC | 20 | Q1 2023 | 6.5% |
View M.D. Sass, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-15 |
View M.D. Sass, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.